What To Expect From Agilent's (A) Q4 Earnings [Yahoo! Finance]
Bio-Techne Corp (TECH)
Last bio-techne corp earnings: 4/30 06:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.bio-techne.com
Company Research
Source: Yahoo! Finance
Here's what you need to know. Agilent beat analysts' revenue expectations by 1.8% last quarter, reporting revenues of $1.70 billion, flat year on year. It was a slower quarter for the company, with a miss of analysts' full-year EPS guidance estimates and organic revenue in line with analysts' estimates. Is Agilent a buy or sell going into earnings? Read our full analysis here, it's free This quarter, analysts are expecting Agilent's revenue to be flat year on year at $1.67 billion, improving from the 5.6% decrease it recorded in the same quarter last year. Adjusted earnings are expected to come in at $1.27 per share. Agilent Total Revenue Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Agilent has only missed Wall Street's revenue estimates once over the last two years, exceeding top-line expectations by 1.8% on average. Looking at Agilent's pee
Show less
Read more
Impact Snapshot
Event Time:
TECH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TECH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TECH alerts
High impacting Bio-Techne Corp news events
Weekly update
A roundup of the hottest topics
TECH
News
- Bio-Techne to Present at the 2026 J.P. Morgan Healthcare ConferencePR Newswire
- Bio-Techne (TECH): Revisiting Valuation as Recent Gains Contrast a Weak One-Year Shareholder Return [Yahoo! Finance]Yahoo! Finance
- Bio-Techne (NASDAQ:TECH) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.MarketBeat
- Bio-Techne (NASDAQ:TECH) was given a new $72.00 price target on by analysts at Deutsche Bank Aktiengesellschaft.MarketBeat
- Here's Why BioTechne (TECH) Traded Lower in Q3 [Yahoo! Finance]Yahoo! Finance
TECH
Earnings
- 11/5/25 - Beat
TECH
Sec Filings
- 11/14/25 - Form SCHEDULE
- 11/5/25 - Form 4
- 11/5/25 - Form 4
- TECH's page on the SEC website